Human and rat beta cells differ in glucose transporter but not in glucokinase gene expression.

Glucose homeostasis is controlled by a glucose sensor in pancreatic beta-cells. Studies on rodent beta-cells have suggested a role for GLUT2 and glucokinase in this control function and in mechanisms leading to diabetes. Little direct evidence exists so far to implicate these two proteins in glucose recognition by human beta-cells. The present in vitro study investigates the role of glucose transport and phosphorylation in beta-cell preparations from nondiabetic human pancreata. Human beta-cells differ from rodent beta-cells in glucose transporter gene expression (predominantly GLUT1 instead of GLUT2), explaining their low Km (3 mmol/liter) and low VMAX (3 mmol/min per liter) for 3-O-methyl glucose transport. The 100-fold lower GLUT2 abundance in human versus rat beta-cells is associated with a 10-fold slower uptake of alloxan, explaining their resistance to this rodent diabetogenic agent. Human and rat beta-cells exhibit comparable glucokinase expression with similar flux-generating influence on total glucose utilization. These data underline the importance of glucokinase but not of GLUT2 in the glucose sensor of human beta-cells.

[1]  H. Lodish,et al.  Differential localization of two glucose transporter isoforms in rat kidney. , 1990, The American journal of physiology.

[2]  L. Slieker,et al.  Glucose Transporter Levels in Tissues of Spontaneously Diabetic Zucker fa/fa Rat (ZDF/drt) and Viable Yellow Mouse (Avy/a) , 1992, Diabetes.

[3]  K. Clément,et al.  Primary pancreatic beta-cell secretory defect caused by mutations in glucokinase gene in kindreds of maturity onset diabetes of the young , 1992, The Lancet.

[4]  R. Unger,et al.  Diabetic hyperglycemia: link to impaired glucose transport in pancreatic beta cells. , 1991, Science.

[5]  J. H. Johnson,et al.  The high Km glucose transporter of islets of Langerhans is functionally similar to the low affinity transporter of liver and has an identical primary sequence. , 1990, The Journal of biological chemistry.

[6]  M. J. MacDonald,et al.  Elusive Proximal Signals of β-Cells for Insulin Secretion , 1990, Diabetes.

[7]  N. Welsh,et al.  Major species differences between humans and rodents in the susceptibility to pancreatic beta-cell injury. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[8]  J. H. Johnson,et al.  Roles of insulin resistance and beta-cell dysfunction in dexamethasone-induced diabetes. , 1992, The Journal of clinical investigation.

[9]  J. Leahy,et al.  The loss of GLUT2 expression by glucose-unresponsive beta cells of db/db mice is reversible and is induced by the diabetic environment. , 1992, The Journal of clinical investigation.

[10]  C. Newgard,et al.  STZ Transport and Cytotoxicity: Specific Enhancement in GLUT2-Expressing Cells , 1994, Diabetes.

[11]  M. Permutt,et al.  Linkage Analysis of GLUT1 (HepG2) and GLUT2 (Liver/Islet) Genes in Familial NIDDM , 1992, Diabetes.

[12]  G. Asins,et al.  Expression of GLUT-2 antisense RNA in beta cells of transgenic mice leads to diabetes. , 1994, The Journal of biological chemistry.

[13]  S. Bonner-Weir,et al.  Loss of glucose-induced insulin secretion and GLUT2 expression in transplanted β-cells , 1995, Diabetes.

[14]  D. Pipeleers,et al.  Differences in glucose handling by pancreatic A- and B-cells. , 1983, The Journal of biological chemistry.

[15]  J. H. Johnson,et al.  Underexpression of beta cell high Km glucose transporters in noninsulin-dependent diabetes , 1990, Science.

[16]  P. Lacy,et al.  Cloning and functional expression of a human pancreatic islet glucose-transporter cDNA. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[17]  D. Finegold,et al.  The Glucokinase Glucose Sensor in Human Pancreatic Islet Tissue , 1986, Diabetes.

[18]  J. H. Johnson,et al.  Engineering of glucose-stimulated insulin secretion and biosynthesis in non-islet cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[19]  J. H. Johnson,et al.  Transfection of AtT-20ins cells with GLUT-2 but not GLUT-1 confers glucose-stimulated insulin secretion. Relationship to glucose metabolism. , 1993, The Journal of biological chemistry.

[20]  H. Lodish,et al.  Expression and function of GLUT-1 and GLUT-2 glucose transporter isoforms in cells of cultured rat pancreatic islets. , 1992, The Journal of biological chemistry.

[21]  M. Permutt,et al.  A mutation in the Glut2 glucose transporter gene of a diabetic patient abolishes transport activity. , 1994, The Journal of biological chemistry.

[22]  M. Permutt,et al.  Glucokinase as pancreatic beta cell glucose sensor and diabetes gene. , 1993, The Journal of clinical investigation.

[23]  T. J. Wheeler,et al.  Kinetic properties of the reconstituted glucose transporter from human erythrocytes. , 1981, The Journal of biological chemistry.

[24]  M. Permutt,et al.  Glucokinase Gene is Genetic Marker for NIDDM in American Blacks , 1992, Diabetes.

[25]  D. Pipeleers,et al.  Differences in Glucose Transporter Gene Expression between Rat Pancreatic α- and β-Cells Are Correlated to Differences in Glucose Transport but Not in Glucose Utilization (*) , 1995, The Journal of Biological Chemistry.

[26]  G. Bell,et al.  Expression of human glucose transporters in Xenopus oocytes: kinetic characterization and substrate specificities of the erythrocyte, liver, and brain isoforms. , 1991, Biochemistry.

[27]  G. Weir,et al.  Ribozyme-mediated attenuation of pancreatic beta-cell glucokinase expression in transgenic mice results in impaired glucose-induced insulin secretion. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[28]  F M Matschinsky,et al.  Glucokinase as Glucose Sensor and Metabolic Signal Generator in Pancreatic β-Cells and Hepatocytes , 1990, Diabetes.

[29]  L. Orci,et al.  Reduced beta-cell glucose transporter in new onset diabetic BB rats. , 1990, The Journal of clinical investigation.

[30]  H. Imura,et al.  Abnormal facilitative glucose transporter gene expression in human islet cell tumors. , 1993, The Journal of clinical endocrinology and metabolism.

[31]  P. Lacy,et al.  Alloxan uptake by isolated rat islets of Langerhans. , 1978, Endocrinology.

[32]  J. H. Johnson,et al.  GLUT-2 gene transfer into insulinoma cells confers both low and high affinity glucose-stimulated insulin release. Relationship to glucokinase activity. , 1994, The Journal of biological chemistry.

[33]  C. Wollheim,et al.  Tissue-specific expression of glucokinase: identification of the gene product in liver and pancreatic islets. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[34]  K. Jungermann,et al.  Functional specialization of different hepatocyte populations. , 1989, Physiological reviews.

[35]  E. Schaftingen,et al.  Heterogeneity in glucose sensitivity among pancreatic beta‐cells is correlated to differences in glucose phosphorylation rather than glucose transport. , 1993, The EMBO journal.

[36]  G. Korbutt,et al.  Prolonged exposure of human pancreatic islets to high glucose concentrations in vitro impairs the beta-cell function. , 1992, The Journal of clinical investigation.

[37]  F. Matschinsky,et al.  Regulation of Glucose Metabolism in Pancreatic Islets , 1981, Diabetes.